Skip to main content
. 2012 Aug 31;4(1):12. doi: 10.1186/1868-7083-4-12

Table 2.

Concomitant JAK2 mutation and SFRP-2 hypermethylation in MPN patients

  CML (n = 10)   PV (n = 10) ET (n = 10) MF (n = 27)  
SFRP-2
U
M
U
M
U
M
U
M
JAK2, wt
10
0
1
1
4
1
12
1
JAK2V617F 0 0 6 2 2 3 8 6

CML, chronic myeloid leukemia; ET, essential thrombocythemia; M, methylated; MF, myelofibrosis; PV, polycythemiavera; U, unmethylated; wt = negative for JAK2V617F.